InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by McCormick Shawn, Director. Director active across 2 companies, notably NEVRO CORP. In total, 17 reports have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €742k. History available since 24 May 2021. The latest transaction was filed on 2 December 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to McCormick Shawn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
1,200 shares@ US$139.0034.3% of flowCommon StockSEC:0001104659-25-118455:0
2,000 shares@ US$127.4879.7% of flowCommon StockSEC:0001104659-25-117422:0
4,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001104659-25-057436:0
1,266 shares0Common StockSEC:0001104659-25-044673:0
46,035 sharesCommon StockSEC:0000950170-25-050474:0
800 shares@ US$220.0092.5% of flowCommon StockSEC:0001104659-24-098967:0
8,537 shares@ US$0.944.2% of flowCommon StockSEC:0001104659-24-090124:0
19,169 shares0Common StockSEC:0001610717-24-000265:0
2,500 shares@ US$0.941.3% of flowCommon StockSEC:0001104659-24-060582:0
716 shares0Common StockSEC:0001104659-24-057563:0
7,500 shares@ US$22.884457.6% of flowCommon StockSEC:0001610717-23-000108:0
Canonical exit: 5 Sept 2023 (T+90)
6,754 shares0Common StockSEC:0001610717-23-000075:0
669 shares0Common StockSEC:0001104659-23-054646:0
4,000 shares@ US$0.942.1% of flowCommon StockSEC:0001104659-23-035049:0
4,155 shares0Common StockSEC:0001567619-22-011892:0
4,155 shares0Common StockSEC:0001567619-22-011889:0
482 shares@ US$149.6526.9% of flowCommon StockSEC:0001567619-21-011219:0
17 of 17 declarations
About McCormick Shawn
McCormick Shawn is Administrateur at Inspire Medical Systems, Inc. (XNAS) and NEVRO CORP (XNAS). He has 17 filings in total, and across the 17 sampled recent filings between 2021-05-26 and 2025-12-04, the reported amounts are EUR 160293 in buys and EUR 582003 in sells, with the modal transaction nature listed as Attribution.
